Thomas Adamkiewicz to Streptococcus pneumoniae
This is a "connection" page, showing publications Thomas Adamkiewicz has written about Streptococcus pneumoniae.
Connection Strength
0.517
-
Yee ME, Abel L, Kalmus G, Patel A, Elmontser M, Bakshi N, Wang YF, Gonzalez MD, Adamkiewicz TV, Yildirim I, Lane PA. Clinical Features and Outcomes of Pneumococcal Bacteremia in Children With Sickle Cell Disease in the Pneumococcal Conjugate Vaccine Era. Pediatr Blood Cancer. 2025 Sep; 72(9):e31881.
Score: 0.231
-
Payne AB, Gierke R, Xing W, McGee L, Hulihan M, Adamkiewicz TV, Kobayashi M. Prevention of Invasive Pneumococcal Disease Among Black or African American Children With and Without Sickle Cell Disease in the United States After Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2005 Through 2019. Pediatr Blood Cancer. 2025 Mar; 72(3):e31467.
Score: 0.223
-
Obert CA, Miller ML, Montgomery J, Adamkiewicz T, Tuomanen EI. Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients. Antimicrob Agents Chemother. 2007 Jan; 51(1):386-9.
Score: 0.063